Despite the fact that MLL-rearranged leukemia is characterized by the presence of a common gene-expression signature [6], the disease is now considered to be heterogeneous and composed of several disease subtypes defined by specific gene-expression signatures and subtype-specific leukemogenic mechanisms [7–9]. This evidence concerns the gene KMT2A and leukemia.